Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million 
Source: Streetwise Reports (01/28/2021)
	
	
		
		
		 Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19.
		
		
	Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19.
     read more >
	
	Imagin Medical Is Bringing Cystoscopy into the 21st Century 
Source: Dr. KSS, MD, PhD, for Streetwise Reports (01/21/2021)
	
	
		
		
		 Dr. KSS, MD, PhD, editor-in-chief of PubBio.co, profiles a small cap that "is poised to bring to clinic a next-generation of must-have cystoscopy equipment."
		
		
	Dr. KSS, MD, PhD, editor-in-chief of PubBio.co, profiles a small cap that "is poised to bring to clinic a next-generation of must-have cystoscopy equipment."
     read more >
	
	A Solace to the Stress of the SolarWinds Hack 
Source: Jack Hurley for Streetwise Reports (01/21/2021)
	
	
		
		
		 Against the backdrop of the massive SolarWinds hack, value investor Jack Hurley discusses his investment thesis for Leonovus Inc, whose products provide an "ironclad level of cybersecurity."
		
		
	Against the backdrop of the massive SolarWinds hack, value investor Jack Hurley discusses his investment thesis for Leonovus Inc, whose products provide an "ironclad level of cybersecurity." 
     read more >
	
	Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD 
Source: Streetwise Reports (01/15/2021)
	
	
		
		
		 Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereye™ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease.
		
		
	Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereye™ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease.
     read more >
	
	Neurosciences Firm Outlines Strategic Priorities for 2021 
Source: Streetwise Reports (01/15/2021)
	
	
		
		
		 ProMIS Neurosciences discusses its four priority areas in 2021.
		
		
	ProMIS Neurosciences discusses its four priority areas in 2021.
     read more >
	
	This Tiny Digital Healthcare Company's Sales Should Rocket Higher 
Source: Matt Badiali for Streetwise Reports (01/06/2021)
	
	
		
		
		 Independent financial analyst Matt Badiali profiles a small cap whose blood glucose monitoring system works with any smartphone.
		
		
	Independent financial analyst Matt Badiali profiles a small cap whose blood glucose monitoring system works with any smartphone.
     read more >
	
	This Tiny Tech Stock Is Quietly Building a Huge Business in Air Quality 
Source: Matt Badiali for Streetwise Reports (01/05/2021)
	
	
		
		
		 Independent financial analyst Matt Badiali discusses how mCloud's technology is making it possible for office buildings to reopen during the pandemic.
		
		
	Independent financial analyst Matt Badiali discusses how mCloud's technology is making it possible for office buildings to reopen during the pandemic.
     read more >
	
	DermTech Shares Rise 32% on Geisinger Health Support for Skin Cancer Test 
Source: Streetwise Reports (12/30/2020)
	
	
		
		
		 Shares of DermTech Inc. climbed to a new 52-week high after the company reported it has received positive medical coverage by Geisinger Health System for its pigmented lesion assay, a non-invasive test for detecting melanoma.
		
		
	Shares of DermTech Inc. climbed to a new 52-week high after the company reported it has received positive medical coverage by Geisinger Health System for its pigmented lesion assay, a non-invasive test for detecting melanoma.
     read more >
	
	California Biotech Advances Two COVID-19 Products 
Source: Streetwise Reports (12/30/2020)
	
	
		
		
		 Recent news concerning Sorrento Therapeutics' SARS-CoV-2 virus test and antibodies is discussed in a Dawson James Securities report.
		
		
	Recent news concerning Sorrento Therapeutics' SARS-CoV-2 virus test and antibodies is discussed in a Dawson James Securities report.
     read more >
	
	BioTelemetry Shares Beat Higher on Royal Philips $2.8 Billion Buyout Offer 
Source: Streetwise Reports (12/18/2020)
	
	
		
		
		 Shares of BioTelemetry Inc. rise 16.5% to a new 52-week high after Royal Philips agreed to acquire the company for US$2.8 billion, or US$72.00 per share in an all cash transaction.
		
		
	Shares of BioTelemetry Inc. rise 16.5% to a new 52-week high after Royal Philips agreed to acquire the company for US$2.8 billion, or US$72.00 per share in an all cash transaction.
     read more >